Trademark: 90392562
Word
RX+
Status
Dead
Status Code
711
Status Date
Friday, October 13, 2023
Serial Number
90392562
Registration Number
6656643
Registration Date
Tuesday, March 1, 2022
Mark Type
3000
Filing Date
Friday, December 18, 2020
Published for Opposition
Tuesday, December 14, 2021
Cancellation Date
Friday, October 13, 2023

Trademark Owner History
Astellas Pharma Inc. - Original Registrant

Classifications
41 Instruction in the field of dosage management; entertainment services, namely, providing online computer games; providing therapeutic exercise instruction; sports club services, namely, physical fitness instruction
9 Downloadable medical software for processing and displaying images on ultrasound medical imaging machines, downloadable computer software for controlling and managing patient medical information, downloadable medical software for processing and displaying affected part images on medical resonance imaging machines (MRIs), downloadable software for medical imaging equipment, namely, for interpreting the results of CT scanners, downloadable computer programs for use in the operation of medical ultrasound detectors, computer software for medical examination for the treatment of type2 diabetes mellitus, metabolic syndrome, bladder disorder, gastroesophageal reflex disease, fecal incontinence, glaucoma, cancer, cognitive impairment associated with schizophrenia, ophthalmology, arrhythmia and bile duct and for conducting medical diagnostic testing
5 Pharmaceutical preparations for the treatment of type2 diabetes mellitus, metabolic syndrome, bladder disorder, gastroesophageal reflex disease, fecal incontinence, glaucoma, cancer, cognitive impairment associated with schizophrenia, ophthalmology, arrhythmia and bile duct; Reagent paper for medical purposes
44 Medical service, medical diagnostic testing services, surgery support services related to medical care for type2 diabetes mellitus, metabolic syndrome, bladder disorder, gastroesophageal reflex disease, fecal incontinence, glaucoma, cancer, cognitive impairment associated with schizophrenia, ophthalmology, arrhythmia and bile duct
10 Medical apparatus for detecting and treating for the treatment of type2 diabetes mellitus, metabolic syndrome, bladder disorder, gastroesophageal reflex disease, fecal incontinence, glaucoma, cancer, cognitive impairment associated with schizophrenia, ophthalmology, arrhythmia and bile duct and diagnostic imaging
42 Providing temporary use of on-line non-downloadable computer programs for use in medical examination for the treatment of type2 diabetes mellitus, metabolic syndrome, bladder disorder, gastroesophageal reflex disease, fecal incontinence, glaucoma, cancer, cognitive impairment associated with schizophrenia, ophthalmology, arrhythmia and bile duct, research and development services in the field of scientific or medical field, providing scientific research information in the field of clinical trials
The mark consists of the characters "Rx+" in red, with rounded grey shapes above and below the text.
The color(s) red and grey is/are claimed as a feature of the mark.
"RX"

Trademark Events
Oct 14, 2023
Notice Of Cancellation Sec. 7 Surrender Emailed
Oct 13, 2023
Cancelled Section 7-Total
Feb 28, 2023
Request For Sect 7 Total Surrender Filed
Oct 10, 2023
Case Assigned To Post Registration Paralegal
Feb 28, 2023
Teas Section 7 Surrender Received
Jun 3, 2022
Teas Change Of Correspondence Received
Jun 3, 2022
Teas Change Of Domestic Representatives Address
Jun 3, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 3, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 1, 2022
Registered-Principal Register
Dec 14, 2021
Official Gazette Publication Confirmation E-Mailed
Dec 14, 2021
Published For Opposition
Nov 24, 2021
Notification Of Notice Of Publication E-Mailed
Nov 5, 2021
Approved For Pub - Principal Register
Nov 5, 2021
Examiner's Amendment Entered
Nov 5, 2021
Notification Of Examiners Amendment E-Mailed
Nov 5, 2021
Examiners Amendment E-Mailed
Nov 5, 2021
Examiners Amendment -Written
Nov 3, 2021
Teas/Email Correspondence Entered
Nov 3, 2021
Correspondence Received In Law Office
Nov 3, 2021
Assigned To Examiner
Oct 27, 2021
Teas Response To Office Action Received
May 17, 2021
Notification Of Non-Final Action E-Mailed
May 17, 2021
Non-Final Action E-Mailed
May 17, 2021
Non-Final Action Written
May 12, 2021
Assigned To Lie
May 8, 2021
Assigned To Examiner
Apr 30, 2021
Assigned To Examiner
Mar 2, 2021
Notice Of Design Search Code E-Mailed
Mar 1, 2021
New Application Office Supplied Data Entered
Feb 2, 2021
Teas Voluntary Amendment Received
Dec 22, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24